Egypt EDA Medical Device Registration Guide (2026): Process, Fees & Timeline

Egypt's Medical Device Market: An Underserved Giant

Egypt is the second-largest medical device market in the MENA region and the most populous country in the Arab world, with over 105 million people. The Egyptian medical devices market was valued at approximately $4.37 billion in 2024 and is projected to reach $5.58 billion by 2032, growing at a CAGR of 3.1%. The country's healthcare expenditure was approximately 5% of GDP, and the health insurance market is expected to expand from $5.67 billion in 2022 to $11.39 billion by 2030 at a CAGR of 9.1%.

Egypt is heavily import-dependent for medical devices, with limited local manufacturing capacity. This creates a significant opportunity for international manufacturers — but one that requires navigating the Egyptian Drug Authority (EDA) registration process.

Since September 2018, medical device registration has been mandatory in Egypt. All devices must be registered with the EDA before they can be imported, marketed, or distributed. The regulatory framework has evolved rapidly in recent years, with the EDA introducing digital submission through the MeDevice portal (launched July 2021), a fast-track pathway, and significant simplification measures announced in February 2026.

This guide provides a complete walkthrough of the EDA registration process, current as of April 2026.

The Egyptian Drug Authority (EDA)

Institutional Structure

The Egyptian Drug Authority (EDA) was established under Law No. 151 of 2019 as the national regulatory body reporting directly to the Prime Minister. It oversees the registration, licensing, and regulation of:

• Pharmaceuticals
• Medical devices
• Biologicals
• Cosmetics
• Related raw materials

The EDA's Central Administration of Medical Devices manages device-specific regulatory activities. For registration purposes, two additional bodies are involved:

• Central Administration of Pharmaceutical Affairs (CAPA): Provides regulatory oversight for device registration
• Drug Policy and Planning Center (DPPC): Assesses technical data and conducts scientific review

The EDA ensures product safety, quality, and effectiveness through inspections, laboratory analysis, and evaluation of clinical research aligned with international standards.

Regulatory Foundation

The key regulation governing medical devices is Egyptian Medical Device Law No. 10 of 2003, supplemented by EDA-issued guidelines and procedures. The EDA's regulatory approach increasingly aligns with international standards from the IMDRF, EU MDR, and US FDA.

Device Classification System

Egypt does not maintain its own unique classification scheme. Instead, the EDA fully adopts the EU classification framework:

Medical Devices

EDA Class	EU MDR Equivalent	Risk Level	Examples
Class I	Class I	Low	Bandages, examination gloves, manual surgical instruments
Class IIa	Class IIa	Low–Moderate	Infusion pumps, powered wheelchairs, hearing aids
Class IIb	Class IIb	Moderate–High	Ventilators, surgical lasers, implantable neurostimulators
Class III	Class III	High	Heart valves, cardiovascular stents, pacemakers, total joint replacements

IVD Devices

IVD Class	Risk Level	Examples
Class A	Low	Specimen receptacles, instruments for sample preparation
Class B	Low–Moderate	Self-testing devices (pregnancy tests), clinical chemistry controls
Class C	Moderate–High	Blood glucose self-testing, infectious disease screening, genetic testing
Class D	High	Blood group typing, HIV/HTLV screening, companion diagnostics

Classification depends on the intended use, duration of patient contact, and degree of invasiveness — the same principles used in the EU MDR Annex VIII classification rules.

Registration Exemptions

• Non-sterile Class I medical devices: Exempt from mandatory registration but must be listed in the importer's EDA record. The license holder can list the device in the importation record without waiting for a registration certificate.
• Reusable surgical instruments: Commonly handled through a listing procedure rather than full registration. However, accessories intended for use exclusively with such instruments may still trigger scientific review and registration requirements.

Practical note: All sterile medical devices, regardless of risk class, are subject to mandatory registration. If your device is sterile Class I, you need full EDA registration.

Recommended Reading

ISO 13485 Certification: Budget, Auditor Expectations & Certification Body Selection (2026)

ISO 13485 Quality Systems2026-04-14 · 23 min read

Step-by-Step Registration Process

Step 1: Appoint an Egyptian Registration Holder (ERH)

Foreign manufacturers without a direct presence in Egypt must designate a local representative known as an Egyptian Registration Holder (ERH). The ERH can be:

• A commercial distributor
• An EDA-licensed scientific office
• A locally established legal entity

The ERH is responsible for:

• Submitting registration applications to the EDA
• Managing all regulatory communications
• Maintaining post-market surveillance obligations
• Import permit coordination
• Vigilance reporting and recall management

Important: In the ERH structure, the ERH can also act as the importer unless the manufacturer has appointed another party. Scientific offices can authorize a third-party importer to handle importation. License transfers are not possible — choosing the right ERH from the outset is critical.

Step 2: Classify the Device

Determine the appropriate classification using EU MDR principles. The EDA has introduced an AI-powered classification tool on its portal to assist manufacturers. For complex or borderline devices, the EDA can provide an official classification opinion. Classification review takes approximately 1–2 weeks.

Step 3: Prepare the Registration Dossier

The technical dossier should be structured according to EDA requirements, which increasingly align with IMDRF-compliant documentation formats. The EDA accepts:

• CSDT (Common Submission Dossier Template) format
• EU MDR or US FDA-based dossiers with clear mapping to EDA requirements

Core dossier components:

Administrative Documents:

• Completed registration application form
• Authorization letter to the ERH (legalized)
• ISO 13485:2016 certificate (mandatory for all applicants)
  • If leveraging FDA clearance, the EDA accepts a Certificate of Foreign Government (CFG) certifying compliance with 21 CFR Part 820 in lieu of ISO 13485
• Certificate of Free Sale from the country of origin
• Declaration of Conformity
• CE certificate or FDA clearance (if applicable — not required but strengthens the application)

Technical Documents:

• Device description, intended use, and indications
• Product composition and materials
• Risk classification rationale
• Essential principles checklist
• Technical file or summary technical documentation
• Clinical evaluation report or performance evaluation data
• GMDN coding
• Packaging configurations and storage conditions
• Shelf life and stability data
• Sterilization details (if applicable)

Labeling:

• Labels and artwork (Arabic and English)
• Instructions for Use (Arabic and English)
• Catalogues and brochures
• Promotional materials

Additional:

• Pharmacovigilance commitment letter (signed by manufacturer)
• Representative product samples (standard component of submission)
• Test reports (biocompatibility, electrical safety, etc. as applicable)

For IVDs, additional requirements include:

• Performance evaluation data aligned with ISO 15189 and/or CLSI guidelines
• Analytical and clinical performance studies
• Stability and lot-to-lot consistency data

Step 4: Submit via the MeDevice Portal

Registration applications are submitted electronically through the EDA's MeDevice platform (launched July 11, 2021) at medevice.edaegypt.gov.eg. The ERH manages the submission process through this platform, which serves as the central interface for:

• Document upload
• Application tracking
• Status monitoring
• Communication with EDA

Step 5: Administrative Screening

The EDA performs an initial administrative screening to assess dossier completeness and formal compliance:

• Normal track: Response within 5 working days (acceptance, rejection, or suspension until requirements are met)
• Fast track: Response within 3 working days

If the application is accepted, the official review begins.

Step 6: Technical Review

The technical review involves multiple stages:

1. File checking against the checklist (7–20 working days)
2. Evaluation by Technical Committee or Central Administration
3. For higher-risk devices: Scientific Committee review (adds 2–3 months)
4. Registration license issuance (1–2 weeks post-approval)

If the EDA requests additional documentation or clarifications, the manufacturer/ERH must fulfill requirements within 60 working days.

Step 7: Obtain Registration License

Upon approval, the EDA issues a registration license with the following validity:

Device Type	Validity
Medical devices	10 years
IVDs	5 years

Renewal applications must be submitted during the first 3 months of the last year of validity.

Registration Pathways and Timelines

Normal Track

Process Step	Estimated Timeline
Risk Classification	1–2 weeks
Administrative Screening	5 working days
Dossier Review	3–6 months
Scientific Committee Review (if needed)	+2–3 months
Certificate Issuance	1–2 weeks
Total Estimated Timeline	4–10 months

For non-sterile devices, the EDA may authorize importation before registration is approved, using a temporary acceptance number. Companies are given 18 months from acceptance of the initial registration file to complete the full registration process, with the first 6 months devoted to submitting essential documents.

Fast-Track Route

The EDA offers a fast-track route for qualifying devices:

• Target: Single-use devices and devices with reference market approvals
• Initial acceptance: 3–4 days
• Application review: 3–4 months
• Caveat: Higher fees apply, and actual timelines may exceed official targets if issues arise during review

Fee Structure

Service	Normal Track	Fast Track
Evaluation per imported device	$59	$258
Bundling (2–10 devices)	$139	$437
Bundling (11–20 devices)	$179	$477
Bundling (21–30 devices)	$219	$516
Bundling (31–40 devices)	$258	$556
Bundling (41–50 devices)	$298	$596

Some sources cite fees of approximately $450/device (normal track) and $1,280/device (fast track) for individual device registration, reflecting the full service including administrative costs. Confirm current fee schedules directly with the EDA or your ERH before submission.

There are no separate manufacturer registration fees.

Recommended Reading

MDSAP Audit Preparation: Complete Guide for Medical Device Manufacturers (2026)

MDSAP ISO 134852026-04-14 · 23 min read

February 2026 Simplification Measures

On February 12, 2026, the EDA's Central Administration of Medical Devices announced a set of procedural facilitations designed to reduce administrative friction in the registration process. These changes are significant for regulatory teams managing Egypt market access:

1. Relationship Letters Between Company Branches

• Before: Letters documenting relationships between corporate branches required prior legalization
• After: Acceptable via the company's official authenticated email — no prior legalization required at submission
• The applicant must provide a commitment letter to submit the legalized version within a specified timeframe

2. Free Sale Certificate (FSC) Requirements

• Before: The FSC had to be valid for at least 3 months prior to submission
• After: A valid FSC is accepted regardless of its remaining validity period
• If electronic verification is not possible, Commercial Chamber legalization is sufficient

3. Streamlined Pre-Registration Import

• The process for obtaining temporary acceptance numbers for importation during the registration period has been simplified
• The EDA is targeting delays at the front end of the process to improve time-to-market

Impact

These facilitations do not lower the EDA's standards for product safety, quality, or performance. Instead, they remove unnecessary administrative barriers that have historically caused delays. Organizations that quickly align their documentation strategies with the new facilitated procedures will be best positioned for faster, more predictable registration.

Post-Market Obligations

The EDA mandates a comprehensive post-market surveillance framework:

Post-Market Surveillance Plan (PMSP)

All registered devices must have a PMSP that includes:

• Complaint handling procedures
• Adverse event reporting:
  • Serious incidents: within 10 days
  • Non-serious incidents: within 30 days
• Periodic Safety Update Reports (PSURs): Required at intervals determined by device risk class
• Vigilance reporting: Coordinated through the ERH

Import and Distribution

Once registered, importation can begin. Requirements include:

• Manufacturer and devices must be listed on the ERH's Importation Record with the EDA
• The ERH must obtain an Import Permit (takes approximately 6–8 weeks)
• Importation records must be maintained and available for EDA inspection

Labeling and Language Requirements

All labels, packaging, and instructions for use must be provided in Arabic and English. Specific requirements include:

• Device identification (name, model/catalog number)
• Manufacturer name and address
• Storage conditions and shelf life
• Instructions for safe use
• Warnings and contraindications
• UDI (Unique Device Identification) if applicable

The EDA is increasingly requiring UDI compliance, aligned with international trends.

Recommended Reading

Medical Device Registration Cost by Country: 2026 Global Comparison

510(k) CE Marking2026-04-14 · 26 min read

Common Challenges and How to Avoid Them

1. Incomplete documentation. The most common cause of delays. Prepare all documents per the EDA checklist before submission. Use the February 2026 facilitations to streamline the process.

2. ERH selection. License transfers are not possible. Choose an ERH with established EDA relationships, regulatory expertise in your device category, and commercial capability to manage your distribution network.

3. Legalization delays. Certificates of Free Sale and authorization letters require legalization. Start this process early — it can add 4–8 weeks to your timeline.

4. Classification disagreements. If the EDA reclassifies your device to a higher risk class, the review process becomes more rigorous and takes longer. Request a classification opinion early if your device falls into a borderline category.

5. Arabic translation quality. Poor Arabic translations of technical documents and IFUs are a frequent source of deficiency letters. Use specialized medical device translators with regulatory documentation experience.

6. Underestimating timelines. Despite published timelines of 4–9 months, the realistic end-to-end process — from ERH appointment through registration certificate issuance — typically takes 6–12 months for Class II devices and 9–18 months for Class III devices.

Market Entry Strategy

For manufacturers entering the Egyptian market, a phased approach works best:

1. Appoint an experienced ERH with a track record in your device category and strong EDA relationships
2. Register your highest-revenue devices first, leveraging any existing CE marking or FDA clearance to support the fast-track pathway
3. Use the bundling system for non-sterile devices to reduce per-device registration costs
4. Begin importation early using the temporary acceptance number for non-sterile devices while completing full registration
5. Build a compliance infrastructure for post-market surveillance, including complaint handling, vigilance reporting, and PSUR preparation
6. Monitor regulatory evolution. The EDA is actively refining its processes. Egypt–Turkey regulatory harmonization talks may eventually lead to mutual recognition agreements for certain device classes

Egypt's combination of market size, import dependence, and an evolving regulatory framework makes it a compelling — but demanding — market for medical device manufacturers. Companies that invest in understanding the EDA's requirements and building strong local partnerships will be best positioned to capture the opportunity.